Authors/Disclosures
|
Niels Borgstein, MD
(Alkermes)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Dawn M. Wilson
(Biogen Idec UK & Ireland)
|
No disclosure on file |
|
Eric Haltom
(Biogen)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jasbir Seehra, PhD
|
Dr. Seehra has received personal compensation for serving as an employee of Keros Therapeutics. Dr. Seehra has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Modal Therapeutics. Dr. Seehra has or had stock in Keros Therapeutics. |
|
Matthew L. Sherman, MD
|
No disclosure on file |